Please login to the form below
Nippon Shinyaku
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nippon Shinyaku's Japan sales performance.
Biosimilar Remicade reaches market in Japan and India
Biosimilar Remicade reaches market in Japan and India. Nippon Kayaku’ s version of arthritis drug was approved in July. ... In Japan, Nippon Kayaku has launched a biosimilar version of Remicade (infliximab) originally developed by South Korean
Deal Watch table for September 2013
50. 5. Shin Nippon Biomedical / Transcept Pharma. Licence. TO-2070 nasal powder for acute migraine.
First biosimilar mAb gets the nod in EU
In Japan the drug will be co-marketed by Celltrion's development partner Nippon Kayaku.
New formulations of Pralia and Enbrel head list of new drugs in Japan
The established version of the drug contained 40mg telmisartan and the same dose of amlodipine, and the line extension - which like its predecessor will be co-promoted by Nippon Boehringer Ingelheim -
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Science Writer – Healthcare Advertising
-
Salary TBC
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
Subscribe to our email news alerts
- 30 Women Leaders in UK Healthcare
- New trial results suggest CAR-T effects are durable in lymphoma
- Moving annual total (MAT)
- 30 Women Leaders in UK Healthcare (part 2)
- More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease
- Positive mid-stage trial gives Allergy’s investors some welcome relief
- Advancing women in healthcare
- Patient engagement hygiene factors
- Another R&D flop for Incyte, but Jakafi keeps delivering
- Heron boosted by new data for ‘breakthrough’ pain drug
- Daily Brief: Airbus relocation woes, inflated taxes will pay for NHS boost, NICE OK's Sanofi's Dupixent and more
- Roche reshuffles its executive committee, again
PMHub
90TEN Healthcare
90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...
Latest intelligence
- Advancing women in healthcare
- Fostering the next generation of leaders...
- The Challenges Of UX In Healthcare: Technology To Change Lives
- Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
- It’s all about patient outcomes… right?
- Lessons from history: a design thinking perspective...
Quick links
Infographics
